The world is full of tradeoffs—it’s the way progress is made while proportionately managing ...
Getting clinical trials to the finish line is not easy. Between 15% to 40% ...
PM360 asked experts in clinical trials about the evolution of decentralized research and what ...
Clinical trial protocol writing teams usually start with scientific objectives, and ideally with the ...
Patients’ directly reported outcomes in certain rare and chronic diseases are considered reliable for ...
In the pharmaceutical business, as with any other business, you can’t market what you ...
Selecting the right Contract Research Organization (CRO) for your clinical trial is a common ...
Substantial unmet needs exist in the diagnosis and treatment of gynecologic cancers. Often, these ...
Clinical trial recruitment is a lengthy and complex process involving stringent protocols and the ...
While digital therapeutics (DTx) companies are extremely optimistic about the promise of software-based interventions ...
As with many other areas of healthcare, COVID-19 has accelerated the transformation of clinical ...
Rare diseases were in the spotlight recently when an early-stage clinical trial involving gene-editing ...
The healthcare industry’s traditional model for medical research long has been costly, slow, and ...